Statistics for Vor Biopharma (id:8136 VOR)
Valuation metrics
Market cap
54.58M
Enterprise value
4.93M
Trailing P/E (ttm)
-0.45
Forward P/E
-0.67
PEG ratio
-0.67
Price/Sales (ttm)
Price/Book (mrq)
0.36
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.04
Overview
Shares outstanding
68.67M
Float
31.98M
Shares short
1.71M
% Held by insiders
0.01%
% Held by institutions
0.81%
Average volume (10 days)
512.37K
Average volume (90 days)
Price summary
52-Week low
0.63
52-Week high
3.14
52-Week change
-137.98%
Beta
-0.41
50-Day moving average
0.80
200-Day moving average
1.33
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-39.74%
Return on equity
-78.07%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-121,204,000.00
Net income to common (ttm)
-118,094,000.00
Diluted EPS (ttm)
-1.64
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
85.94M
Total cash per share (mrq)
1.26
Total debt (mrq)
33.82M
Total Debt/Equity (mrq)
34.48
Current ratio (mrq)
654.00%
Book value per share (mrq)
2.22
Cash flow
Cash flow statement
-104,236,000.00
Levered free cash flow (LFCF)
-63,337,624.00